Johns Hopkins University spinout Blade Therapeutics has attracted $45m in commitments from investors including Pfizer, Novartis and Bristol-Myers Squibb.

Northwestern University and Osage University Partners are among the investors in a series A round for the neurological disorder treatment developer, spun out of Northwestern spinout Naurex.

Nexeon, the Imperial College London spinout that develops rechargeable lithium ion batteries, has now secured in excess of $120m.

Adidas and Qualcomm's corporate venturing units both contributed to a series C round that will fund sales and marketing for 360fly's immersive 360-degree video cameras.

EPFL spinout Nexthink, which uses artificial intelligence to monitor and analyse network traffic and is backed by Mannai Corporation, raises $40m to drive international expansion.

The diagnostics platform developer, spun out of Tufts University, secures additional capital from a consortium featuring the institution.

University College London cancer treatment spinout Autolus licences additional technology from the university as it raises $57m in its series B round.

Biotechnology spinout Aprea has secured the largest funding round of any Karolinska Development portfolio company to date.